Search results
Results From The WOW.Com Content Network
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. [3] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US ...
Neurocrine Biosciences Inc’s (NASDAQ:NBIX): Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in ...
For premium support please call: 800-290-4726 more ways to reach us
What: Shares of biotech company Neurocrine. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
William Rastetter. William H. (aka Bill) Rastetter (born 1948), a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, [4] and of Daré Bioscience, Inc. [5] in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a ...
Early life and education. Vale was born in Houston, Texas, on July 3, 1941. He completed a B.A. degree in biology at Rice University and obtained a Ph.D. in physiology and biochemistry from Baylor College of Medicine. He commenced employment at the Salk Institute for Biological Studies in San Diego, California, in 1970.
Technically Neurocrine Biosciences was up 90% today, but it dropped so much after the first trial, the biotech is only sitting on a relatively modest gain from Neurocrine Biosciences Inc. Nearly ...
Indiplon ( INN and USAN) is a nonbenzodiazepine, hypnotic sedative that was developed in two formulations—an immediate-release formulation for sleep onset, and a modified-release (also called controlled-release or extended-release) version for sleep maintenance.